Skip to content

Laparoscopic Sleeve Gastrectomy in Severely Obese Adolescents: Effects on Metabolism

Laparoscopic Sleeve Gastrectomy in Severely Obese Adolescents: Effective for Resolution of Cardiovascular Comorbidities

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02594514
Enrollment
22
Registered
2015-11-03
Start date
2007-01-31
Completion date
2014-12-31
Last updated
2015-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Surgery

Keywords

cardiovascular risk, metabolic profile

Brief summary

Severe obesity (SO), defined as BMI≥95th percentile, has increased worldwide among adolescents. American studies estimated that 1.3-2.8% of 12-19-year-old individuals have a BMI \>40 kg/m2 or a BMI \>35 kg/m2 with at least one serious co-morbidity. The immediate and long-term risks associated with SO in adolescents include cardiovascular and metabolic diseases, obstructive sleep apnoea and nonalcoholic fatty liver disease. However, the results of sleeve gastrectomy in adolescents are still uncertain. Objective and hypotheses: Investigators aimed to assess the long-term safety, efficacy, and cardiovascular risk changes of laparoscopic sleeve gastrectomy in adolescents with SO. Method: Longitudinal retrospective study of 22 adolescents with SO who underwent laparoscopic sleeve gastrectomy. Clinical and metabolic variables immediately before surgery and after 6, 12, 18 and 24 months were assessed.

Interventions

None listed

Sponsors

University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* ages of 14 and 19 * submitted to LSG between 2007 and 2014. * attended the child obesity clinic of the pediatric endocrinology department of the Instituto da Criança da Universidade de São Paulo (Children's Institute of University of São Paulo). * received clinical and pharmacological treatment for at least 6 months before surgery and were followed by a multidisciplinary team including a pediatric endocrinologist, a nutritionist, a psychologist and a physical educator. * BMI \> 40 kg/m2 or BMI \> 35 kg/m2 with comorbidities and failed to achieve significant weight loss (10% of initial weight at 6 months) through clinical treatment. * Both the patients and their guardians were informed about the risks and benefits of surgery and provided informed consent.

Exclusion criteria

* it was a retrospective study

Design outcomes

Primary

MeasureTime frameDescription
Percent of loss of excess weight following laparoscopic sleeve gastrectomy in severely obese adolescentsup to 24 monthsweight
percent of reduction in body mass index following laparoscopic sleeve gastrectomy in severely obese adolescentsup to 24 monthsweight and stature

Secondary

MeasureTime frameDescription
Changes in glucose and and fractions following laparoscopic sleeve gastrectomy in severely obese adolescentsup to 24 monthsoral glucose tolerance test
Changes in transaminases following laparoscopic sleeve gastrectomy in severely obese adolescentsup to 24 monthslaboratory assessment-
Changes in uric acid following laparoscopic sleeve gastrectomy in severely obese adolescentsup to 24 monthslaboratory assessment-
Changes in insulin resistance following laparoscopic sleeve gastrectomy in severely obese adolescentsup to 24 monthslaboratory assessment- fasting insulinemia
Changes in abdominal ultrasonography ( steatosis )following laparoscopic sleeve gastrectomy in severely obese adolescentsup to 24 monthsabdominal ultrasonography
Changes in echocardiogram ( concentric hypertrophy of left ventricle )following laparoscopic sleeve gastrectomy in severely obese adolescentsup to 24 monthsechocardiogram
Changes in triglycerides following laparoscopic sleeve gastrectomy in severely obese adolescentsup to 24 monthslaboratory assessment-
Changes in total cholesterol and and fractions following laparoscopic sleeve gastrectomy in severely obese adolescentsup to 24 monthslaboratory assessment-

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026